Frank Rimerman Advisors LLC increased its stake in MetLife, Inc. (NYSE:MET – Free Report) by 14.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,115 shares of the financial services provider’s stock after purchasing an additional 1,163 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in MetLife were worth $746,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Bank of New York Mellon Corp raised its holdings in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after purchasing an additional 4,606,748 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares during the period. Nordea Investment Management AB raised its holdings in MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after acquiring an additional 608,224 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in MetLife by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider’s stock valued at $320,430,000 after acquiring an additional 30,187 shares during the period. Finally, Swedbank AB raised its holdings in MetLife by 76.0% during the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after acquiring an additional 1,496,645 shares during the period. 94.99% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Keefe, Bruyette & Woods decreased their price target on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a report on Wednesday, February 12th. Barclays dropped their price target on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen boosted their target price on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Finally, JPMorgan Chase & Co. boosted their target price on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.58.
MetLife Stock Performance
Shares of NYSE:MET opened at $80.62 on Friday. The company has a market capitalization of $54.92 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The firm has a 50 day moving average of $83.44 and a 200 day moving average of $82.45.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date was Tuesday, February 4th. MetLife’s payout ratio is presently 36.52%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Expert Stock Trading Psychology Tips
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Why is the Ex-Dividend Date Significant to Investors?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.